跳至主要内容
临床试验/RBR-9x5zrgm
RBR-9x5zrgm招募中Unknown

Influence of different photobiomodulation protocols on prevention of chemotherapy-induced dygeusia in patients with breast cancer treated with doxorubicine-cyclophosphamide and taxans: Phase III clinical trial, randomized, triple blind.

niversidade Federal do Ceará0 个研究点开始时间: 2023年12月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18Y 至 0(—)
性别
Female

入选标准

  • Patients over 18 years old; breast cancer stages II, III and IV; adjuvant, neoadjuvant or palliative; treatment with drugs Doxorubicin, Cyclophosphamide and Taxol

排除标准

  • Radiotherapy to the head and neck; smokers; anemia; untreated diabetes mellitus; after COVID-19

研究者

发起方
niversidade Federal do Ceará

相似试验